West Pharmaceutical Services | WST - Sales Revenues


West Pharmaceutical Services reported $872.3M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Align Technology USD 1.06B 20M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 1000M 4.2M Jun/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Dentsply International USD 898M 18M Jun/2026
Haemonetics USD 339M 7M Jun/2026
ICU Medical USD 551.68M 25.91M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Neogen USD 225.3M 14.1M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 630.9M 10.9M Jun/2026
Repligen USD 204M 10M Jun/2026
Rockwell Medical USD 25.83M 3.15M Jun/2024
Solventum Corp USD 2.2B 190M Jun/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Utah Medical Products USD 8.72M 323K Mar/2026
West Pharmaceutical Services USD 872.3M 27.4M Jun/2026